{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:52:20Z","timestamp":1790527940906,"version":"4.1.0"},"reference-count":60,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["522002003"],"award-info":[{"award-number":["522002003"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["CO\u2010NL\u2010276\u20104222"],"award-info":[{"award-number":["CO\u2010NL\u2010276\u20104222"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["CO\u2010US\u2010276\u20101712"],"award-info":[{"award-number":["CO\u2010US\u2010276\u20101712"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","award":["PHNL\/JAN\/0714\/0005b\/1912fde"],"award-info":[{"award-number":["PHNL\/JAN\/0714\/0005b\/1912fde"]}],"id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","award":["3000268822"],"award-info":[{"award-number":["3000268822"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","award":["3000747780"],"award-info":[{"award-number":["3000747780"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Intern AIDS Soc"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>In settings where both daily and event\u2010driven pre\u2010exposure prophylaxis (Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>) are offered to men who have sex with men (<jats:styled-content style=\"fixed-case\">MSM<\/jats:styled-content>), a clear understanding of the motives to choose between the different dosing\u2010regimens can facilitate more effective Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content> implementation. We therefore studied the motives for choosing for, switching between, and stopping daily or event\u2010driven Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used data (August 2015\u2010June 2017) from the prospective, longitudinal, open\u2010label Amsterdam Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content> demonstration study, in which daily (<jats:styled-content style=\"fixed-case\">dPrEP<\/jats:styled-content>) and event\u2010driven Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content> (edPr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>) were offered to 374 <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010negative <jats:styled-content style=\"fixed-case\">MSM<\/jats:styled-content> and two transgender persons. Participants self\u2010selected the preferred Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>\u2010regimen at baseline and could switch regimens at three\u2010monthly follow\u2010up visits. We measured motives for choosing Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>\u2010regimen at baseline and for switching and stopping Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content> at follow\u2010up visits. Open\u2010 and closed\u2010end items were combined and qualitatively analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Choices of Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>\u2010regimens were determined by personal and contextual factors, involving the perceived self\u2010efficacy concerning adherence, the risk\u2010context, and the anticipated impact of Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content> on physical and sexual wellbeing. <jats:styled-content style=\"fixed-case\">dPrEP<\/jats:styled-content> was preferred because of the anticipated better adherence and the fear of side\u2010effects relating to edPr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content> re\u2010initiations. Moreover, <jats:styled-content style=\"fixed-case\">dPrEP<\/jats:styled-content> was perceived to be more effective than edPr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>. Motives to choose edPr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content> were the expected physical burden of <jats:styled-content style=\"fixed-case\">dPrEP<\/jats:styled-content>, anticipated side\u2010effects of <jats:styled-content style=\"fixed-case\">dPrEP<\/jats:styled-content>, and fear to forget daily doses. Regarding the risk\u2010context: <jats:styled-content style=\"fixed-case\">dPrEP<\/jats:styled-content> was preferred for unplanned and\/or frequent sex, while edPr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content> was chosen when risk was predictable and\/or less frequent. While some chose for <jats:styled-content style=\"fixed-case\">dPrEP<\/jats:styled-content> to gain more sexual freedom, others chose for edPr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content> to minimize sexual risk episodes. Changes in the above factors, such as changing risk patterns, changing relationships or changing physical conditions, resulted in switching regimens. Choices to stop Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content> were related to lower sexual risk, adherence issues and side\u2010effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The great diversity of motives illustrates the importance of offering a choice of Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>\u2010regimens. In counselling of <jats:styled-content style=\"fixed-case\">MSM<\/jats:styled-content> starting Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>, choices for Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>\u2010regimens may be addressed as a continuum of flexible and changeable options over time. This may help individuals choose the Pr<jats:styled-content style=\"fixed-case\">EP<\/jats:styled-content>\u2010regimen that best fits their current sexual context, priorities and personal capabilities and therefore will be more easily adhered to.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jia2.25389","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T06:24:33Z","timestamp":1571120673000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Motives for choosing, switching and stopping daily or event\u2010driven pre\u2010exposure prophylaxis \u2013 a qualitative analysis"],"prefix":"10.1002","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1647-8485","authenticated-orcid":false,"given":"Hanne ML","family":"Zimmermann","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Research and Prevention Public Health Service of Amsterdam Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne W","family":"Eekman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Research and Prevention Public Health Service of Amsterdam Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel CA","family":"Achterbergh","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Public Health Service of Amsterdam STI Outpatient Clinic Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten F","family":"Schim van der Loeff","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Research and Prevention Public Health Service of Amsterdam Amsterdam the Netherlands"},{"name":"Department of Infectious Diseases Amsterdam Institute for Infection and Immunity (AI&amp;II) Amsterdam UMC University of Amsterdam Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Prins","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Research and Prevention Public Health Service of Amsterdam Amsterdam the Netherlands"},{"name":"Department of Infectious Diseases Amsterdam Institute for Infection and Immunity (AI&amp;II) Amsterdam UMC University of Amsterdam Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9784-547X","authenticated-orcid":false,"given":"Henry JC","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Public Health Service of Amsterdam STI Outpatient Clinic Amsterdam the Netherlands"},{"name":"Department of Dermatology Amsterdam Institute for Infection and Immunity (AI&amp;II) Amsterdam UMC University of Amsterdam Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-2109","authenticated-orcid":false,"given":"Elske","family":"Hoornenborg","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Research and Prevention Public Health Service of Amsterdam Amsterdam the Netherlands"},{"name":"Department of Infectious Diseases Public Health Service of Amsterdam STI Outpatient Clinic Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udi","family":"Davidovich","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Research and Prevention Public Health Service of Amsterdam Amsterdam the Netherlands"},{"name":"Department of Infectious Diseases Amsterdam Institute for Infection and Immunity (AI&amp;II) Amsterdam UMC University of Amsterdam Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Consortium (H\u2010TEAM)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001145"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506273"},{"key":"e_1_2_9_6_1","unstructured":"European Medicines Agency (EMA).First medicine for HIV pre\u2010exposure prophylaxis recommended for approval in the EU [press release].London United Kingdom:EMA;2016."},{"key":"e_1_2_9_7_1","unstructured":"World Health Organization (WHO).Consolidated guidelines on HIV prevention diagnosis treatment and care for key populations 2016 update. [cited 2018 Mar 9]. Available from:http:\/\/apps.who.int\/iris\/bitstream\/10665\/246200\/1\/9789241511124-eng.pdf"},{"key":"e_1_2_9_8_1","unstructured":"European AIDS Clinical Society (EACS).European Guidelines for treatment of HIV\u2010positive adults in Europe; Guidelines 9.0. [cited 2018 May 3]. Available from:http:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines\/eacs-guidelines.html"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205663"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30311-5"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/964512"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2016-052699"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005717"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-017-1996-y"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad1863"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402269"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202614"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004910"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2011.554528"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12160-014-9646-3"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2017.1360992"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-015-1238-0"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.5713"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2017.00341"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25211"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11121-017-0799-8"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2045-1"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001939"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001791"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25105"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.111.3.455"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/109019818801500203"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.25.4.462"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.13.3.238"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-013-0429-9"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61852-7"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0752-9"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2095-4"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-7-104"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2013.0116"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70847-3"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001511"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000647"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0958-x"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/13691058.2016.1164899"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2015.0186"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-012-0317-8"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089118"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-013-0617-7"},{"key":"e_1_2_9_50_1","unstructured":"MugoN.Implementation science: making the new prevention revolution real. XIX International AIDS Conference; 24th July; Washington DC;2012."},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182986f69"},{"issue":"4","key":"e_1_2_9_52_1","doi-asserted-by":"crossref","first-page":"19983","DOI":"10.7448\/IAS.18.4.19983","article-title":"Beyond \u201cgetting drugs into bodies\u201d: social science perspectives on pre\u2010exposure prophylaxis for HIV","volume":"18","author":"Auerbach JD","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.20.1.21842"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.12372"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.19.1.20777"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30008-0"},{"key":"e_1_2_9_57_1","unstructured":"HoornenborgE.Incident HIV Hepatitis C and other STI in daily and event\u2010driven PrEP users. 25th Conference on Retroviruses and Opportunistic Infections (CROI); Boston MA;2018."},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00137"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302816"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-017-1964-6"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.4683"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjia2.25389","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25389","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jia2.25389","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T22:19:54Z","timestamp":1694211594000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.25389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1002\/jia2.25389"],"URL":"https:\/\/doi.org\/10.1002\/jia2.25389","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"2019-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e25389"}}